Qian Li
Army Medical University(CN)Sun Yat-sen University(CN)Chinese Academy of Sciences(CN)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)Fudan University(CN)Soochow University(CN)Zhongshan Hospital(CN)The First Affiliated Hospital, Sun Yat-sen University(CN)The Affiliated Yongchuan Hospital of Chongqing Medical University(CN)Southwest Hospital(CN)Shenzhen Institutes of Advanced Technology(CN)Guang’anmen Hospital(CN)Qinghai Provincial Peoples Hospital(CN)First Affiliated Hospital of Soochow University(CN)YangPu Geriatric Hospital(CN)University of Chinese Academy of Sciences(CN)Chongqing Medical University(CN)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, MicroRNA in disease regulation, Colorectal Cancer Treatments and Studies, Cancer Genomics and Diagnostics, Lung Cancer Treatments and Mutations
Most-Cited Works
- → PD-1/PD-L1 checkpoint inhibitors in advanced hepatocellular carcinoma immunotherapy(2022)210 cited
- → Efficacy and safety of camrelizumab combined with apatinib in advanced triple-negative breast cancer: an open-label phase II trial(2020)176 cited
- → Low-Dose Anti-Angiogenic Therapy Sensitizes Breast Cancer to PD-1 Blockade(2019)144 cited
- → Mesenchymal stem cells stimulate intestinal stem cells to repair radiation-induced intestinal injury(2016)114 cited
- → Screening and Identification of Linear B-Cell Epitopes and Entry-Blocking Peptide of Severe Acute Respiratory Syndrome (SARS)-Associated Coronavirus Using Synthetic Overlapping Peptide Library(2005)73 cited
- → Circulating miR-19a and miR-205 in Serum May Predict the Sensitivity of Luminal A Subtype of Breast Cancer Patients to Neoadjuvant Chemotherapy with Epirubicin Plus Paclitaxel(2014)